Duality Biotherapeutics (HKG:9606) said the Shanghai Stock Exchange accepted the application materials for the proposed share issue and listing on the Science and Technology Innovation Board, according to a Friday Hong Kong bourse filing.
Shares of the biotechnology company were up over 3% in Monday's late-morning trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments